User profiles for Cécile Emeraud
Cécile EmeraudAssistant professor, Paris Saclay University, MEdecine Faculty Verified email at aphp.fr Cited by 620 |
Aztreonam plus clavulanate, tazobactam, or avibactam for treatment of infections caused by metallo-β-lactamase-producing Gram-negative bacteria
C Emeraud, L Escaut, A Boucly… - Antimicrobial agents …, 2019 - Am Soc Microbiol
Metallo-β-lactamase (MBL)-producing Gram-negative bacteria are often extremely resistant,
leading to a real therapeutic dead end. Here, we evaluated the in vitro and in vivo efficacy of …
leading to a real therapeutic dead end. Here, we evaluated the in vitro and in vivo efficacy of …
[HTML][HTML] Genetic diversity, biochemical properties, and detection methods of minor carbapenemases in Enterobacterales
RA Bonnin, AB Jousset, C Emeraud, S Oueslati… - Frontiers in …, 2021 - frontiersin.org
Gram-negative bacteria, especially Enterobacterales, have emerged as major players in
antimicrobial resistance worldwide. Resistance may affect all major classes of anti-gram-…
antimicrobial resistance worldwide. Resistance may affect all major classes of anti-gram-…
Using artificial intelligence to improve COVID-19 rapid diagnostic test result interpretation
Serological rapid diagnostic tests (RDTs) are widely used across pathologies, often providing
users a simple, binary result (positive or negative) in as little as 5 to 20 min. Since the …
users a simple, binary result (positive or negative) in as little as 5 to 20 min. Since the …
[HTML][HTML] Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant Enterobacterales
Objectives Cefiderocol is a catechol-substituted cephalosporin dedicated to the treatment of
infections caused by multidrug resistant gram-negative rods. Cefiderocol susceptibility …
infections caused by multidrug resistant gram-negative rods. Cefiderocol susceptibility …
[HTML][HTML] Emergence of new non–clonal group 258 high-risk clones among Klebsiella pneumoniae carbapenemase–producing K. pneumoniae isolates, France
…, AB Jousset, A Chiarelli, C Emeraud… - Emerging Infectious …, 2020 - ncbi.nlm.nih.gov
The worldwide spread of Klebsiella pneumoniae carbapenemase–producing Klebsiella
pneumoniae (KPC-Kp) isolates was reported to be caused by dissemination of 1 clonal complex …
pneumoniae (KPC-Kp) isolates was reported to be caused by dissemination of 1 clonal complex …
[HTML][HTML] Outbreak of CTX-M-15 Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae ST394 in a French Intensive Care Unit Dedicated to COVID-19
C Emeraud, S Figueiredo, RA Bonnin, M Khecharem… - Pathogens, 2021 - mdpi.com
Infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae (ESBL-KP)
are constantly rising worldwide and are often reported as causative agent of …
are constantly rising worldwide and are often reported as causative agent of …
[HTML][HTML] Uncovering the novel Enterobacter cloacae complex species responsible for septic shock deaths in newborns: A cohort study
D Girlich, S Ouzani, C Emeraud, L Gauthier… - The Lancet …, 2021 - thelancet.com
Background Enterobacter cloacae complex contains nosocomial pathogens responsible for
infection outbreaks. Identification at the species level within the E cloacae complex remains …
infection outbreaks. Identification at the species level within the E cloacae complex remains …
Rapid selection of a cefiderocol-resistant Escherichia coli producing NDM-5 associated with a single amino acid substitution in the CirA siderophore receptor
…, S Yilmaz, A Bleibtreu, C Emeraud… - Journal of …, 2023 - academic.oup.com
Cefiderocol is a novel siderophore-conjugated cephalosporin that is very promising for the
treatment of infections caused by MDR bacteria. Its main advantages reside in its stability …
treatment of infections caused by MDR bacteria. Its main advantages reside in its stability …
Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam
RA Bonnin, S Bernabeu, C Emeraud, E Creton… - International Journal of …, 2022 - Elsevier
Relebactam and vaborbactam are among the newest β-lactamase inhibitors marketed. They
were originally designed to inhibit the Ambler class A carbapenemase KPC. In this study, …
were originally designed to inhibit the Ambler class A carbapenemase KPC. In this study, …
Evaluating 10 commercially available SARS-CoV-2 rapid serological tests by use of the STARD (Standards for Reporting of Diagnostic Accuracy Studies) method
…, C Langendorf, DA Mendels, C Emeraud… - Journal of clinical …, 2021 - Am Soc Microbiol
Numerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapid serological
tests have been developed, but their accuracy has usually been assessed using very few …
tests have been developed, but their accuracy has usually been assessed using very few …